Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11299309rdf:typepubmed:Citationlld:pubmed
pubmed-article:11299309lifeskim:mentionsumls-concept:C0162291lld:lifeskim
pubmed-article:11299309lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:11299309lifeskim:mentionsumls-concept:C0010656lld:lifeskim
pubmed-article:11299309lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:11299309lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:11299309lifeskim:mentionsumls-concept:C0205374lld:lifeskim
pubmed-article:11299309lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:11299309lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:11299309pubmed:issue2lld:pubmed
pubmed-article:11299309pubmed:dateCreated2001-4-20lld:pubmed
pubmed-article:11299309pubmed:abstractTextEmerging evidence supports an important role for caspases in neuronal death following ischemia-reperfusion injury. This study assessed whether cell specific caspases participate in neuronal degeneration and whether caspase inhibition provides neuroprotection following transient retinal ischemia. We utilized a model of transient global retinal ischemia. The spatial and temporal pattern of the active forms of caspase 1, 2 and 3 expression was determined in retinal neurons following ischemic injury. Double-labeling with cell-specific markers identified which cells were expressing different caspases. In separate experiments, animals received various caspase inhibitors before the induction of ischemia. Sixty minutes of ischemia resulted in a delayed, selective neuronal death of the inner retinal layers at 7 days. Expression of caspase 1 was not detected at any time point. Maximal expression of caspase 2 was found at 24 h primarily in the inner nuclear and ganglion cell layers of the retina and localized to ganglion and amacrine neurons. Caspase 3 also peaked at 24 h in both the inner nuclear and outer nuclear layers and was predominantly expressed in photoreceptor cells and to a lesser extent in amacrine neurons. The pan caspase inhibitor, Boc-aspartyl fmk, or an antisense oligonucleotide inhibitor of caspase 2 led to significant histopathologic and functional improvement (electroretinogram) at 7 days. No protection was found with the caspase 1 selective inhibitor, Y-vad fmk. These observations suggest that ischemia-reperfusion injury activates different caspases depending on the neuronal phenotype in the retina and caspase inhibition leads to both histologic preservation and functional improvement. Caspases 2 and 3 may act in parallel in amacrine neurons following ischemia-reperfusion. These results in the retina may shed light on differential caspase specificity in global cerebral ischemia.lld:pubmed
pubmed-article:11299309pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:languageenglld:pubmed
pubmed-article:11299309pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:citationSubsetIMlld:pubmed
pubmed-article:11299309pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11299309pubmed:statusMEDLINElld:pubmed
pubmed-article:11299309pubmed:monthAprlld:pubmed
pubmed-article:11299309pubmed:issn0022-3042lld:pubmed
pubmed-article:11299309pubmed:authorpubmed-author:RothSSlld:pubmed
pubmed-article:11299309pubmed:authorpubmed-author:SinghMMlld:pubmed
pubmed-article:11299309pubmed:authorpubmed-author:GuptaGGlld:pubmed
pubmed-article:11299309pubmed:authorpubmed-author:RosenbaumP...lld:pubmed
pubmed-article:11299309pubmed:authorpubmed-author:RosenbaumD...lld:pubmed
pubmed-article:11299309pubmed:authorpubmed-author:SavitzS ISIlld:pubmed
pubmed-article:11299309pubmed:authorpubmed-author:HoqueRRlld:pubmed
pubmed-article:11299309pubmed:issnTypePrintlld:pubmed
pubmed-article:11299309pubmed:volume77lld:pubmed
pubmed-article:11299309pubmed:ownerNLMlld:pubmed
pubmed-article:11299309pubmed:authorsCompleteYlld:pubmed
pubmed-article:11299309pubmed:pagination466-75lld:pubmed
pubmed-article:11299309pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:meshHeadingpubmed-meshheading:11299309...lld:pubmed
pubmed-article:11299309pubmed:year2001lld:pubmed
pubmed-article:11299309pubmed:articleTitleCell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia.lld:pubmed
pubmed-article:11299309pubmed:affiliationDepartment of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.lld:pubmed
pubmed-article:11299309pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11299309pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11299309pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11299309lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11299309lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11299309lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11299309lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11299309lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11299309lld:pubmed